CCT FORTIS-OLD(00138) announced annual performance, with a net loss attributable to shareholders of approximately 327 million Hong Kong dollars, a decrease of 17.4% compared to the previous year.
China Construction Wealth Management (00138) released its annual results for the year ending December 31, 2025, with revenue of 606 million Hong Kong dollars, an increase of 14.3% year-on-year. The company's equity holders' share of the net loss was approximately 327 million Hong Kong dollars, a decrease of 17.4% compared to the previous year. Basic and diluted loss per share was 2.04 Hong Kong dollars.
CCT FORTIS-OLD (00138) announced its annual performance for the year ending December 31, 2025, with a revenue of 606 million Hong Kong dollars, an increase of 14.3% compared to the previous year. The net loss attributable to equity owners of the company was approximately 327 million Hong Kong dollars, a decrease of 17.4% year-on-year. The basic and diluted loss per share was 2.04 Hong Kong dollars.
The announcement stated that the main losses for the year were from non-cash fair value losses on film investments, impairment losses on receivables and assets classified as held for sale totaling approximately 64 million Hong Kong dollars, approximately 5 million Hong Kong dollars, and approximately 79 million Hong Kong dollars respectively.
Related Articles

PASHUN INT'L (00574) announced a net loss of 15.856 million yuan in 2025, a year-on-year increase of 3.55%.

Understanding Jiuyuan Gene (02566) 2025 annual performance in one picture: Performance remains resilient, focusing on research and development to enhance long-term competitiveness.

GMTEight List of A-share restricted sales and lifting restrictions | March 31st
PASHUN INT'L (00574) announced a net loss of 15.856 million yuan in 2025, a year-on-year increase of 3.55%.

Understanding Jiuyuan Gene (02566) 2025 annual performance in one picture: Performance remains resilient, focusing on research and development to enhance long-term competitiveness.

GMTEight List of A-share restricted sales and lifting restrictions | March 31st

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


